The Office of Technology Development manages Memorial Sloan Kettering’s world-class portfolio of intellectual property. We are responsible for:
- Identifying and evaluating new inventions
- Seeking patent protection
- Developing, managing, and commercializing the institution’s innovations
- Facilitating start-up creation.
The goal of our technology transfer activities is to ensure that scientific research at Memorial Sloan Kettering is developed and applied for the common good.
For information about material transfer agreements or other contracts, contact one of our contract analysts.
The Office of Technology Development’s mission is to ensure that Memorial Sloan Kettering’s inventions have the greatest chance of benefiting patients.
The office is staffed by technology transfer professionals with backgrounds in science, intellectual property, and business development.
Research conducted at Memorial Sloan Kettering has produced ten drugs FDA approved for marketing, and one product approved by the USDA.
Technologies Available for Licensing
We offer opportunities for developing new devices, diagnostics, research tools, therapeutics, and vaccines.
Tangible Materials Available for Licensing
We have an extensive collection of tangible research materials, including cell lines, antibodies, reagents, and mouse models, which are available for licensing on a non-exclusive basis for research and commercial purposes.
Learn more about how to reach us by phone, e-mail, regular mail, or courier.